Cochrane for Clinicians - Jul 1, 2006 - American Family Physician
Jul 1, 2006 - Intravenous lidocaine and oral mexiletine provide a modest reduction in neuropathic pain with no indication of serious adverse effects. However, safety data are limited because most studies were of relatively short duration and fewer than 400 patients have been studied in total for each...
American Family Physician : Cochrane for Clinicians
https://www.aafp.org/afp/2006/0701/p79.html
navigate_before 1 navigate_next